Skip to content

A clinical trial to study the effects of two drugs, Poly-herbal capsules and Pregabelin in patients of diabetes mellitus with diabetic neuropathy.

Evaluation of the role of a poly-herbal formulation in management of diabetic neuropathy with special reference to prameha upadrava. - DNCT

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/01/006533
Enrollment
120
Registered
2016-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients known case of Diabetes Mellitus with diabetic neuropathy

Interventions

Intervention1: Poly-herbal capsule: Poly-herbal capsule 1500 mg BD Orally for 6 months Control Intervention1: Gabapentin : Gabapentine 75 mg TDS for 6 months

Sponsors

Dr Kumudini S Sawale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of diabetes mellitus; BSL fasting less than 140 mg/dl, glycosylated hemoglobin below 7) with oral glucose-lowering agents and /or insulin; Patients with clinical signs and symptoms of diabetic neuropathy with one or more than one nerve involved. Patients with impaired nerve conduction studies of one or more than one peripheral nerve Patient does not require any emergency treatment for neuropathy. Blood pressure below or equal to 160/90 mmHg at both Screening and Baseline. In addition, blood pressure, if measured, must have been stable in hypertensive patients over the 3 months prior to Screening, with no more than 1 blood pressure reading not more than 160/90 mmHg

Exclusion criteria

Exclusion criteria: Any neurological condition requiring urgent medical or surgical intervention Any other serious systemic disease within the last 3 months; With obvious symptoms or signs of liver diseases, ALT or AST more than two times normal upper limit; Severe edema or serous cavity effusion Drug abuse Suffering from any malignancy. Receiving the long-term systematic steroid, hormone treatment Gestation already, prepares to be pregnant in the period of the trial, lactating women; Participate in other product clinical trial within 30 days prior to this trial. History of previous kidney transplant Patients of autonomic neuropathy

Design outcomes

Primary

MeasureTime frame
Improvement of functions of peripheral nervesTimepoint: Improvement of functions of peripheral nerves

Secondary

MeasureTime frame
Improvement in the clinical signs and symptoms of Diabetic neuropathy Improvement in the nerve conduction velocityTimepoint: 6 months

Countries

India

Contacts

Public ContactKumudini Sukadev Sawale

Ayurved Seva Sanghs Ayurved Mahavidyalaya Nashik

sawale.kumud@gmail.com8983477961

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026